Enhancements    

HUMAN PAPILLOMAVIRUS (HPV) VACCINE ACCEPTANCE: A RANDOMIZED CONTROL TRIAL EXAMINING TRUSTWORTHY MESSENGERS OF VACCINE INFORMATION IN HISPANIC PARENTS

HUMAN PAPILLOMAVIRUS (HPV) VACCINE ACCEPTANCE: A RANDOMIZED CONTROL TRIAL EXAMINING TRUSTWORTHY MESSENGERS OF VACCINE INFORMATION IN HISPANIC PARENTS
PI: Gabriel Frietze
Sponsor: CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS (PILOT PROJECT)
College of Science Dean's Office
Amount awarded: $79,533

This project promotes the uptake of the Human Papillomavirus vaccine (HPV), particularly among Hispanic families, as Hispanics are disproportionately impacted by HPV-associated cancers, which has been magnified by the pandemic.

Posting date: Fri, 01/06/2023

Award start date: Wed, 08/31/2022
Award end date: Wed, 08/30/2023